HUNTINGTON, NY--(Marketwired - Dec 7, 2016) - SeanieMac Ltd. (OTC PINK: BETS), an Irish gaming company, says as of December 6 preliminary numbers show gross profit of about $150,500 US on the new platform. We anticipate a sharp increase in both turnover …
DALLAS, TX and MUMBAI, INDIA--(Marketwired - Dec 7, 2016) - MoneyOnMobile, Inc. (OTCQX: MOMT) announced today that Executive VP, Will Dawson, was recently interviewed on The RedChip Money Report television program. The interview will air Thursday, December …
Substantiated testing data provides quantifiable results - ACAT Performance's tech-advanced catalytic converters reduce emissions while maximizing performance LOS ANGELES, CA, USA, December 6, 2016 /EINPresswire.com/ -- Today, ACAT Performance made an …
FORT WAYNE, Ind., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq:VRA) (“Vera Bradley” or the “Company”) today announced it has entered into three additional licensing agreements in the areas of home, hosiery, and swim. The Company previously …
MARTINSVILLE, Va., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Hooker Furniture (NASDAQ:HOFT) today reported consolidated net sales of $145.3 million and net income of $6.5 million, or $0.56 per diluted share, for its fiscal 2017 third quarter ended October 30, 2016 …
NEWARK, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat indications with high unmet medical need, today announced the initiation of a new Phase 2 …
MALVERN, Pa., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), today announced that its Investigational New Drug (IND) Application for ATI-50001, an orally administered investigational Janus Kinase (JAK) inhibitor, for the …
AUSTIN, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat genetic rare diseases and cancer, today …
AUSTIN, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, today announced that enrollment has been completed in its randomized, double-blind, placebo-controlled Phase III study evaluating …
BURLINGTON, Mass., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ:BLIN) announced today that one of the world’s largest engine manufacturers has selected iAPPS to power its eCommerce website. The engagement is expected to total more …
INDIANAPOLIS, Dec. 07, 2016 (GLOBE NEWSWIRE) -- The Finish Line, Inc. (NASDAQ:FINL) today announced the following webcast: What: Third Quarter Fiscal 2017 Financial Results Conference Call When: Wednesday, December 21, 2016 at 8:30 a.m. Eastern …
SPRINGFIELD, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Village Super Market, Inc. (Nasdaq:VLGEA) today reported its results of operations for the first quarter ended October 29, 2016. Net income was $4,109,000 in the first quarter of fiscal 2017 compared to …
Third quarter net revenues totaled $126.7 million, flat with last year Third quarter net income totaled $8.8 million, or $0.24 per diluted share (including a $0.04 per share income tax benefit related to the release of certain income tax reserves) Company …
DALLAS/FORT WORTH, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of attention-deficit/ …
NEW YORK, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ:XELB) is pleased to announce Christina Caruso as Creative Director for the Judith Ripka brands. With 15 years of experience in fashion accessory and jewelry design, Caruso joins the team …
PRINCETON, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that preclinical data on the potential use of detoxified Listeriolysin O (dtLLO) as an …
SEL-212 Designed to be First Non-Immunogenic Uricase Therapeutic for Severe Gout Data Show Substantial and Sustained Reduction of Serum Uric Acid Levels for 30 Days or Longer After Single Dose Company to Host Conference Call Tomorrow Morning WATERTOWN, …
FORT LAUDERDALE, Fla., Dec. 07, 2016 (GLOBE NEWSWIRE) -- A large nationwide infectious disease observational study in Europe will receive electronic data capture (EDC) technology and related services from OmniComm Systems, Inc. (OTCQX:OMCM), a leading …
Data Safety Monitoring Board (DSMB) for the Study Unconditionally Approves Moving into Fifth Cohort Through Four Cohorts 15 Patients Have Received Escalating Doses of SBP-101 MINNEAPOLIS, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), …
Hancock, MD, Dec. 07, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, is pleased to announce the …
